NEW YORK (GenomeWeb News) – Bioanalytical firm Protea Biosciences today announced four distribution deals.

The Morgantown, W.Va.-based company said that it has inked deals with Yair Technologies for the distribution of Protea products in Israel; with BioAnalytic covering Poland; with Irida Iberica covering Spain and Portugal; and with IDL Teknolojik covering Turkey.

The partners will distribute Protea's sample preparation and mass spectrometry products and its LAESI DP-1000 sample analysis instrument, Protea Vice President and General Manager Alessandro Baldi said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.